CompletedPhase 4

Fat Distribution in Healthy Early Postmenopausal Women

Austria67 participantsStarted 2002-07

Plain-language summary

The aim of this study is to explore the effects of hormone replacement therapy with EV/DNG on abdominal fat distribution measured by magnetic resonance imaging.

Who can participate

Age range48 Years – 60 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Healthy early postmenopausal women * BMI between 25 and 30 Exclusion Criteria: * Contra-indication(s) for hormone treatment * Metabolic diseases * Concomitant medication with influence on lipid metabolism

What they're measuring

Individual relative change of abdominal visceral fat measured by magnetic resonance imaging

Timeframe: Baseline and after 24 weeks of treatment

Trial details

NCT IDNCT00335218

SponsorBayer

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Healthy trials